Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
2401
Saul Centers
BFS
$829M
| $3.69M | ﹤0.01% |
102,419
-6,581
| -6% | -$241K |
|
|
DOO
2402
Bombardier Recreational Products
DOO
$4.68B
| $3.69M | ﹤0.01% |
109,158
+10,004
| +10% | +$440K |
|
2403
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $3.65M | ﹤0.01% |
164,372
+42,353
| +35% | +$872K |
|
2404
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
| $3.65M | ﹤0.01% |
38,286
-3,838
| -9% | -$369K |
|
2405
TechTarget
TTGT
$312M
| $3.63M | ﹤0.01% |
245,338
+19,302
| +9% | +$311K |
|
2406
ArriVent BioPharma
AVBP
$1.44B
| $3.63M | ﹤0.01% |
196,494
-9,885
| -5% | -$242K |
|
2407
Peapack-Gladstone Financial
PGC
$815M
| $3.63M | ﹤0.01% |
127,854
-2,128
| -2% | -$66.8K |
|
|
BBUC
2408
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.13B
| $3.63M | ﹤0.01% |
136,495
+20,445
| +18% | +$520K |
|
2409
PACS Group
PACS
$7.39B
| $3.63M | ﹤0.01% |
322,804
-4,800
| -1% | -$63K |
|
2410
Organogenesis Holdings
ORGO
$310M
| $3.61M | ﹤0.01% |
835,046
-90,614
| -10% | -$366K |
|
|
ALX
2411
Alexander's
ALX
$1.39B
| $3.6M | ﹤0.01% |
17,193
-231
| -1% | -$46.8K |
|
2412
Willis Lease Finance
WLFC
$1.35B
| $3.59M | ﹤0.01% |
68,145
-1,419
| -2% | -$90.2K |
|
2413
Medifast
MED
$136M
| $3.58M | ﹤0.01% |
265,572
+151,434
| +133% | +$2.27M |
|
|
CBL
2414
CBL Properties
CBL
$1.68B
| $3.58M | ﹤0.01% |
134,518
-68,056
| -34% | -$2M |
|
2415
Haverty Furniture Companies
HVT
$450M
| $3.56M | ﹤0.01% |
180,417
+10,944
| +6% | +$240K |
|
|
SAGE
2416
DELISTED
Sage Therapeutics
SAGE
| $3.55M | ﹤0.01% |
446,178
-16,131
| -3% | -$118K |
|
2417
Arm
ARM
$306B
| $3.53M | ﹤0.01% |
33,079
+6,888
| +26% | +$961K |
|
|
NFBK
2418
DELISTED
Northfield Bancorp
NFBK
| $3.53M | ﹤0.01% |
323,167
-7,848
| -2% | -$90.3K |
|
2419
Haleon
HLN
$44.2B
| $3.52M | ﹤0.01% |
342,213
+76,469
| +29% | +$753K |
|
|
SRDX
2420
DELISTED
Surmodics
SRDX
| $3.51M | ﹤0.01% |
115,047
-2,857
| -2% | -$96.2K |
|
2421
Zumiez
ZUMZ
$332M
| $3.47M | ﹤0.01% |
233,020
+7,895
| +4% | +$122K |
|
2422
Honda
HMC
$39.9B
| $3.47M | ﹤0.01% |
127,803
+39,879
| +45% | +$1.14M |
|
|
SFIX
2423
Stitch Fix
SFIX
$538M
| $3.45M | ﹤0.01% |
1,062,918
-162,242
| -13% | -$739K |
|
2424
Riley Exploration Permian
REPX
$739M
| $3.44M | ﹤0.01% |
118,007
-6,569
| -5% | -$211K |
|
2425
Arvinas
ARVN
$560M
| $3.43M | ﹤0.01% |
489,239
-46,873
| -9% | -$735K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.